. Cette-Étude-relève-un-niveau, 1 ± 1,5 mm puis celui-ci va passer à 6,3 ± 1,8 mm et 6,2 ± 1,7 mm à 1 et 5 ans respectivement Donc à 1 an, on aura gagné 3,8 ± 1,9 mm et à 5 ans, 4,1 ± 1,6 mm. Pour ce traitement, on note une petite progression du niveau d'attache jusqu'à 5 ans mais de l

. Dans-cette-Étude, os enregistrées sont faites à partir de radiographies Initialement et à 1 an, 10 sujets sont présents mais, au bout de 5 ans, il n'en reste que plus que 8. La moyenne de la profondeur des lésion infra-osseuses initiale est de 10,4 ± 2,5 mm puis, à 1 an, elle est de 5,6 ± 1,5 mm et enfin, à 5 ans, 2000.

J. M. Albandar, Enamel Matrix Derivative versus bioactive ceramic filler in the treatment of intrabony defects : 12-month results, J. Periodontol, pp.219-227, 1980.

M. G. Araùjo, GTR treatment of degree III furcation defects following application of enamel matrix proteins. An experimental study in dogs, Journal of Clinical Periodontology, vol.2, issue.6, pp.524-530, 1925.
DOI : 10.1111/j.1365-2818.1973.tb04629.x

F. Boabaid, Leuchine-rich amelogenin Peptide: a candidate signaling molecule during cementogenesis, J . Periodontol, pp.1126-1136, 1975.

I. Bokan, Primary flap closure combined with Emdogain® and Cerasorb® in the treatment of intrabony defects, J. Clin. Periodontol, pp.885-893, 1933.

D. D. Bosshardt, Biological mediators and periodontal regeneration: a review of enamel matrix proteins at the cellular and molecular levels, Journal of Clinical Periodontology, vol.86, issue.(Suppl. 1), pp.87-105, 2008.
DOI : 10.1902/jop.1976.47.5.249

G. Bratthall, Comparison of ready-to-use Emdogain®-gel and Emdogain® in patients with chronic adult periodontitis ( a multicenter clinical study ), J. Clin. Periodontol, pp.923-929, 1928.

P. M. Camargo, A controlled re-entry study on the effectiveness of bovine porous bone mineral used in combination with a collagen membrane of porcine origin in the treatment of intrabony defects in humans, Journal of Clinical Periodontology, vol.27, issue.12, pp.889-896, 2000.
DOI : 10.1034/j.1600-051x.2000.027012889.x

P. Cortellini, Treatment of deep and shallow intrabony defects ( a multicentrer randomized controlled clinical trial ), J. Clin. Periodontol, pp.981-987, 1925.

A. Deli, Treatment of intrabony defects using Guided Tissue Regeneration or Enamel Matrix Derivative : a 3 year prospective randomized clinical study, J. Periodontol, pp.2281-2289, 1979.

N. Donos, Wound healing of degree III furcation involvements following Guided Tissue Regeneration and / or Emdogain® ( a histologic study ), J. Clin. Periodontol, pp.1061-1068, 1930.

L. Francetti, Enamel Matrix Proteins in the treatment of intrabony defects ( a prospective 24 -month clinical trial ), J. Clin. Periodontol, pp.52-59, 1931.

C. Galli, Osteoprotegerin and Receptor Activator of Nuclear Factor-Kappa B Ligand Modulation by Enamel Matrix Derivative in Human Alveolar Osteoblasts, Journal of Periodontology, vol.25, issue.7
DOI : 10.1111/j.1600-0501.2004.01088.x

S. Gestrelius, In vitro studies on periodontal ligament cells and enamel matrix derivative, Journal of Clinical Periodontology, vol.34, issue.9, pp.685-692, 1924.
DOI : 10.1016/0092-8674(93)90678-J

L. Guida, In Vitro Biologic Response of Human Bone Marrow Stromal Cells to Enamel Matrix Derivative, Journal of Periodontology, vol.3, issue.3, pp.2190-2196, 1978.
DOI : 10.1902/jop.2002.73.5.543

L. Hammarström, Periodontal regeneration in a buccal dehiscence model in monkeys after application of enamel matrix proteins, Journal of Clinical Periodontology, vol.30, issue.9, pp.669-677, 1924.
DOI : 10.1902/jop.1959.30.1.17

J. Hatakeyama, Amelogenin-mediated Regulation of Osteoclastogenesis, and Periodontal Cell Proliferation and Migration, Journal of Dental Research, vol.85, issue.2, pp.144-149, 1985.
DOI : 10.1016/S0945-053X(01)00155-X

L. Heijl, Enamel Matrix Derivative ( Emdogain® ) in the treatment of inrtabony periodontal defects, J. Clin. Periodontol, pp.705-714, 1924.

N. H. Heng, Enamel matrix derivative induces connective growth factor expression inhuman osteoblastic cells, J. Periodontol, pp.2369-2379, 1978.

M. J. Hoidal, Clinical Evaluation of Demineralized Freeze-Dried Bone Allograft With and Without Enamel Matrix Derivative for the Treatment of Periodontal Osseous Defects in Humans, Journal of Periodontology, vol.20, issue.12, pp.792273-2280, 2008.
DOI : 10.1902/jop.2003.74.9.1282

T. Iwata, Noggin blocks osteoinductive activity of porcine enamel extracts, J. Dent. Res, issue.81, pp.387-391, 2002.

C. D. Kalpidis, Treatment of Intrabony Periodontal Defects With Enamel Matrix Derivative: A Literature Review, Journal of Periodontology, vol.20, issue.11, pp.198-201, 2002.
DOI : 10.1034/j.1600-051x.2002.290102.x

S. Karapataki, Healing following Guided Tissue Regenerative treatment of intrabony defects distal to mandibular second molars using resorbable and non-resorbable barriers, J. Clin. Periodontol, pp.27333-340, 2000.

A. Kasaj, Effect of an oily hydroxyde suspension ( Osteoinductals ) on human periodontal fibroblasts. An in vitro study, Eur. J. Med. Res, issue.12, pp.268-272, 2007.

T. Kawase, Cytostatic action of enamel matrix derivative (EMDOGAINR) on human oral squamous cell carcinoma-derived SCC25 epithelial cells, Journal of Periodontal Research, vol.35, issue.5, pp.291-300, 2000.
DOI : 10.1034/j.1600-0765.2000.035005291.x

T. Kawase, Enamel matrix derivative ( Emdogain® ) rapidly stimulates phophorylation of the MAP kinase family and nuclear accumulation of smad2 in both oral epithelial and fibroblastic human cells, J. Periodontal Res, issue.36, pp.367-376, 2001.

T. Kawase, Anti-TGF-beta antibody blocks enamel matrix derivative-induced upregulation of p21WAF1/cip1 and prevents its inhibition of human oral epithelial cell proliferation, Journal of Periodontal Research, vol.37, issue.4, pp.37255-262, 2002.
DOI : 10.1034/j.1600-0765.2002.01615.x

M. O. Klein, In vitro assessment of motility and proliferation of human osteogenic cells on different isolated extracellular matrix components compared with enamel matrix derivative by continuous single-cell observation, Clinical Oral Implants Research, vol.14, issue.1, pp.40-45, 2007.
DOI : 10.1034/j.1600-0501.2001.012004332.x

B. Kuru, Enamel matrix derivative alone or in combination with a bioactive glass in wide intrabony defects, Clinical Oral Investigations, vol.74, issue.3, pp.227-234, 2006.
DOI : 10.1902/jop.1982.53.12.726

A. Liñares, Guided tissue regeneration/deproteinized bovine bone mineral or papilla preservation flaps alone for treatment of intrabony defects. II: radiographic predictors and outcomes, Journal of Clinical Periodontology, vol.64, issue.5, pp.33351-358, 2006.
DOI : 10.1016/0030-4220(51)90084-9

J. Lindhe, Periodontal tissue alterations following Emdogain® treatment of periodontal sites with angular bone defects ( a series of case reports ), J. Clin. Periodontol, issue.26, pp.855-860, 1999.

S. P. Lyngstadaas and . Et-coll, Autocrine growth factors in human periodontal ligament cells cultured on enamel matrix derivative, Journal of Clinical Periodontology, vol.35, issue.2, pp.181-188, 1928.
DOI : 10.1083/jcb.120.1.253

N. Matsuda, Possible involvement of extracellular signal-regulatedkinase 1

U. Mirastschijski, Effects of a topical enamel matrix derivative on skin wound healing. Wound Repair Regen, pp.100-108, 2004.

T. Nagano, Porcine enamel protein fractions contain transforming growth factor-b1, J.Periodontol, issue.77, pp.1688-1694, 2006.
DOI : 10.1902/jop.2006.050352

S. Naoshi, Atlas clinique de chirurgie parodontale, Paris : Quintescence international, vol.447, 2002.

D. B. Palioto, The Influence of Enamel Matrix Derivative Associated With Insulin-Like Growth Factor-I on Periodontal Ligament Fibroblasts, Journal of Periodontology, vol.17, issue.4, pp.75498-504, 2004.
DOI : 10.1902/jop.2000.71.8.1287

M. Ohyama, Effect of Enamel Matrix Derivative on the Differentiation of C2C12 Cells, Journal of Periodontology, vol.265, issue.5, pp.543-550, 2002.
DOI : 10.1083/jcb.105.2.949

K. Okubo, Participation of endogenous IGF-1 and TGF-?1 with enamel matrix derivative-stimulated cell growth in human periodontal ligament cells, J. Periodontal Res, pp.1-9, 1938.

A. Parashis, Clinical and radiographic findings following application of enamel matrix derivative in the treatment of intrabony defects. A series of case reports, Journal of Clinical Periodontology, vol.27, issue.9
DOI : 10.1034/j.1600-051x.2000.027009705.x

M. H. Parkar and M. Et-tonetti, Gene Expression Profiles of Periodontal Ligament Cells Treated With Enamel Matrix Proteins In Vitro: Analysis Using cDNA Arrays, Journal of Periodontology, vol.66, issue.11, pp.751539-1546, 2004.
DOI : 10.1177/00220345010800030701

G. R. Persson, Treatment of intrabony defects with resorbable materials, nonresorbable materials and flap debridement, J. Clin. Periodontol, pp.169-178, 1927.

M. D. Pietruska and . Et-coll, A comparative study on the use of Bio-Oss® and Enamel Matrix Derivative ( Emdogain® ) in the treatment of periodontal bone defects, J. Clin. Periodontol, issue.109, pp.178-181, 2001.

S. Pischon, Effects of an enamel matrix deriative on human osteoblasts and PDL cells grown in organoid cultures, Oral Surg. Oral Med., Oral Pathol., Oral Radiol, vol.1, pp.2551-557, 2006.

C. R. Richardson, Clinical evaluation of Bio-Oss® : a bovine-derived xenograft for the treatment of periodontal osseous defects in humans, J. Clin. Periodontol, issue.26, pp.421-428, 1999.

J. C. Rincon, Enhanced proliferation, attachment and osteopontine expression by porcine periodontal cells exposed to Emdogain®, Arch. Oral biol, pp.1047-1054, 1950.

T. L. Rodrigues, Effects of enamel matrix derivative and transforming growth factor-b1 on human periodontal ligament fibroblasts, J.Clin.Periodontol, pp.514-522, 1934.

S. R. Schlueter, In Vitro Effects of Enamel Matrix Derivative on Microvascular Cells, Journal of Periodontology, vol.7, issue.1, pp.141-151, 1978.
DOI : 10.1034/j.1600-0765.2003.00690.x

Z. Schwartz, Porcine Fetal Enamel Matrix Derivative Stimulates Proliferation But Not Differentiation of Pre-Osteoblastic 2T9 Cells, Inhibits Proliferation and Stimulates Differentiation of Osteoblast-Like MG63 Cells, and Increases Proliferation and Differentiation of Normal Human Osteoblast NHOst Cells, Journal of Periodontology, vol.122, issue.8, pp.711287-1296, 2000.
DOI : 10.1002/jcb.240500411

A. Sculean, Healing of human intrabony defects following treatment with enamel matrix proteins or guided tissue regeneration, Journal of Periodontal Research, vol.22, issue.6, pp.310-322, 1934.
DOI : 10.1111/j.1600-051X.1987.tb00956.x

A. Sculean, Treatment of intrabony defects with guided tissue regeneration and enamel-matrix-proteins. An experimental study in monkeys, Journal of Clinical Periodontology, vol.27, issue.7, pp.27466-472, 2000.
DOI : 10.1034/j.1600-051x.2000.027007466.x

A. Sculean, Treatment of intrabony defects with enamel matrix proteins and guided tissue regeneration. A prospective controlled clinical study, Journal of Clinical Periodontology, vol.18, issue.5, pp.397-403, 1928.
DOI : 10.1902/jop.1998.69.11.1183

A. Sculean, Healing of intrabony defects following treatment with a bovinederived xenograft and collagen membrane ( a controlled clinical study ), J. Clin

A. Sculean, Five year results following treatment of intrabony defects with Enamel Matrix Proteins and Guidee Tissus Regeneration, J. Clin. Periodontol, pp.545-549, 1927.

A. Sculean, Healing of human intrabony defects following regenerative periodontal therapy with an enamel matrix protein derivative alone or combined with a bioactive glass. A controlled clinical study, Journal of Clinical Periodontology, vol.73, issue.1, pp.32111-117, 2005.
DOI : 10.1034/j.1600-051X.2002.290508.x

A. Sculean, Ten year result after treatment of intrabony defects with an 127

A. Sculean, Ten year result following treatment of intrabony defects with Enamel Matrix Proteins and Guided Tissue Regeneration, J. Clin. Periodontol, pp.817-824, 1935.

P. M. Sipos, The combined use of Enamel Matrix Proteins and a tetracyclinecoated expanted polytetrafluoroethylene barrier membrane in the treatment of intra-osseous defects, J. Clin. Periodontol, pp.32765-772, 2005.

A. Stavropoulos, Five-year results of guided tissue regeneration in combination with deproteinized bovine bone (Bio-Oss) in the treatment of intrabony periodontal defects: a case series report, Clinical Oral Investigations, vol.22, issue.4, pp.271-277, 2005.
DOI : 10.1111/j.1600-0528.1994.tb02050.x

A. Stavropoulos, Bovine bone mineral ( Bio-Oss® ) in the treatment of intrabony periodonal defects : 6-year results from a randomized-controlled clinical trial, J

E. C. Swanson, Amelogenins regulate expression of genes associated with cementoblasts in vitro, European Journal of Oral Sciences, vol.44, issue.s1, pp.239-243, 2006.
DOI : 10.1016/0003-9969(91)90101-Y

Y. Tokiyasu, Enamel Factors Regulate Expression of Genes Associated With Cementoblasts, Journal of Periodontology, vol.106, issue.12, pp.1829-1839, 2000.
DOI : 10.1111/j.1600-0722.1998.tb02188.x

M. S. Tonetti, Healing, post-operative morbidity and patient perception of outcomes following regenerative therapy of deep intrabony defects, Journal of Clinical Periodontology, vol.29, issue.3, pp.311092-1098, 2004.
DOI : 10.1902/jop.1993.64.10.934

M. S. Tonetti, Baseline radiographic defect angle of the intrabony defect as a prognosic indicator in regenerative periodontal surgery with Enamal Matrix Derivative, J

M. S. Tonetti, Clinical outcomes following treatment of human intrabony defects with GTR/bone replacement material or access flap alone. A multicenter randomized controlled clinical trial, Journal of Clinical Periodontology, vol.22, issue.3, pp.31770-776, 2004.
DOI : 10.1034/j.1600-051X.2002.290407.x

M. S. Tonetti, Improved wound stability with a modified minimally invasive surgical technique in the regenerative treatment of isolated interdental intrabony defects, J

L. Trombelli, Autogenous bone graft in conjunction with enamel matrix derivative in the treatment of deep periodontal intra-osseous defects: a report of 13 consecutively treated patients, Journal of Clinical Periodontology, vol.74, issue.3, pp.3369-75, 2006.
DOI : 10.1902/jop.2000.71.5.752

J. Van-der-dolder, The effect of Emdogain on the growth and differentiation of rat bone marrow cells, J. Periodontal Res, pp.471-476, 1941.

P. Van-der, Enamel-matrix-derived proteins stimulates attachment of periodontal ligament fibroblasts and enhances alkaline phosphatase activity and transforming growth factor ?1 release of periodontal ligament and gingival fibroblasts, J. Periodontol, pp.7131-7174, 2000.

H. L. Viswanathan, Amelogenin: A Potential Regulator of Cementum-Associated Genes, Journal of Periodontology, vol.5, issue.10, pp.1423-1431, 2003.
DOI : 10.1006/jsbi.1994.1011

I. Vouros, Guided Tissue Regeneration in intrabony periodontal deects 129 following treatment with two bioabsorbable membranes in combination with bovine bone mineral graft ( a clinical and radiographic study ), J. Clin. Periodontol, pp.31908-917, 2004.

H. Wachtel, Microsurgical access flap and enamel matrix derivative for the treatment of periodontal intrabony defects: a controlled clinical study, Journal of Clinical Periodontology, vol.68, issue.6, pp.496-504, 1930.
DOI : 10.1902/jop.1997.68.10.996

S. Yoneda, The effects of enamel matrix derivative (EMD) on osteoblastic cells in culture and bone regeneration in a rat skull defect, Journal of Periodontal Research, vol.275, issue.3, pp.333-342, 1938.
DOI : 10.1016/S0934-8832(11)80080-6

K. Yuan, Enamel matrix derivative exhibits angiogenic effect in vitro and in a murine model, Journal of Clinical Periodontology, vol.73, issue.8, pp.732-738, 1930.
DOI : 10.1902/jop.2002.73.7.701

E. Zeldish, ERK, Journal of Dental Research, vol.86, issue.1, pp.41-46, 2007.
DOI : 10.1002/cyto.990030503

E. Zeldish, Enamel matrix derivative protects human gingival fibroblasts from TNF-induced apoptosis by inhibiting caspase activation, Journal of Cellular Physiology, vol.86, issue.3, pp.750-758, 0213.
DOI : 10.1177/00220345740530020101